Javier Anguita

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Transcriptomic landscape of peripheral T cells following CAR-T cell therapy in diffuse large B cell lymphoma.

Transcriptomic landscape of peripheral T cells following CAR-T cell therapy in diffuse large B cell lymphoma.

Journal: Cancer immunology, immunotherapy : CII

Published: March 27, 2026

Prognostic value of liver stiffness measurement for complications after allogeneic transplant with post-transplant cyclophosphamide.

Prognostic value of liver stiffness measurement for complications after allogeneic transplant with post-transplant cyclophosphamide.

Journal: Frontiers in immunology

Published: September 04, 2025

Predictive biomarkers validation of CD3+ cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach.

Predictive biomarkers validation of CD3+ cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach.

Journal: Scientific reports

Published: August 26, 2025

Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy.

Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy.

Journal: British journal of haematology

Published: September 20, 2024

Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation.

Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation.

Journal: Frontiers in immunology

Published: March 05, 2024

Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.

Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.

Journal: Transplantation and cellular therapy

Published: September 27, 2023

Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.

Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.

Journal: Blood transfusion = Trasfusione del sangue

Published: May 08, 2023

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.

Journal: Frontiers in immunology

Published: February 14, 2023

Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide.

Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide.

Journal: Annals of hematology

Published: November 28, 2022

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.

Journal: Frontiers in immunology

Published: July 25, 2022

FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia.

FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia.

Journal: Cancers

Published: June 30, 2022

Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy.

Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy.

Journal: Transfusion

Published: March 17, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026